NeoBinder (企业域新说)
Beijing, China
The work of NeoBinder mainly involves space-based AIGC algorithm. In protein design, the team comprehensively uses sequence information, structural information and structure-function correlation information for modeling design. In terms of algorithm research and development, the team focuses on developing new application scenarios such as biosensors. By building its own data set and AI-accelerated simulation algorithm, NeoBinder is committed to maximizing the accuracy of protein design.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2022
- Website
- neobinder.com
Only accessible to MedStartr community members.
Join nowWhat do you think of NeoBinder (企业域新说)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now